The Pharmacy Times® Hematology Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of blood disorders, including blood and bone marrow cancers, leukemia, and myeloma.
June 30th 2025
Pulmonary hypertension significantly increases the risk of disease progression and cardiovascular events in patients with myelofibrosis, emphasizing a need for routine screening.
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Manage...
1.5 Credits / Hematology, Hematologic Cancer, Oncology
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Overcoming Disparities in Multiple Myeloma Treatment: Empowering Pharmacists to Drive Change
1.0 Credit / Health Equity, Diversity & Inclusion, Hematologic Cancer, Hematology, Oncology
View More
Navigating Treatment Evolution in Myelofibrosis: Oncology Pharmacist's Strategies for JAK Inhibitor Optimizati...
1.0 Credit / Hematologic Cancer, Hematology, Oncology
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care
1.5 Credits / Hematologic Cancer, Hematology, Oncology
View More
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and...
1.0 Credit / Oncology, Hematology, Hematologic Cancer
View More
Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma
1.5 Credits / Hematologic Cancer, Oncology, Hematology
View More
Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based R...
1.5 Credits / Hematologic Cancer, Hematology, Oncology
View More
Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management
1.5 Credits / Oncology, Hematology
View More
PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices
0.75 Credit / Oncology, Law
View More
JAK(i) of All Trades: Navigating Myelofibrosis Treatment and Safety in Community Oncology Practice
0.75 Credit / Oncology, Hematologic Cancer, Hematology
View More
Beyond Chimeric Antigen Receptor T-Cell Therapy: Comprehensive Approaches for Community Oncology Practices in ...
0.75 Credit / Oncology, Hematologic Cancer, Hematology
View More
Advancing Chronic Lymphocytic Leukemia Treatment in the Community: Practical Updates and Clinical Pearls for O...
0.75 Credit / Oncology, Hematologic Cancer, Hematology
View More
AACR 2025: Off-the-Shelf CAR NK Therapy SENTI-202 Shows Potential for Complete Remission in R/R AML
April 27th 2025Interim results from the phase 1 SENTI-202-101 trial show that SENTI-202, a logic-gated, off-the-shelf chimeric antigen receptor natural killer (CAR NK) cell therapy, achieved complete remission in 4 patients with relapsed or refractory (R/R) acute myeloid leukemia (AML).
Read More
HOPA 2025: The Promise and Pitfalls of ctDNA Testing in Oncology
April 11th 2025Mark Zangardi, PharmD, MS, BCOP, and Amber Cipriani, PharmD, BCOP, discuss the growing role of circulating tumor DNA (ctDNA) testing in oncology, highlighting its applications in early cancer detection, molecular residual disease assessment, and treatment monitoring.
Read More